Responses
EULAR 2014: Scientific Abstracts
Poster Presentations. Rheumatoid arthritis - non biologic treatment and small molecules
THU0133 Results from A Phase 2A, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study of Jnj-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-Modifying Antirheumatic Drug Therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.